# Renerve

Type: Product

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/renerve
Canonical HTML page: https://getfinancebrief.com/entity/renerve

## Recent coverage (1 stories)

### Orthocell Bolsters Cash to $49.6M Following $3M R&D Tax Refund
2026-02-19 19:46:51 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Orthocell Limited has secured a $3 million R&D tax incentive refund, elevating its total cash reserves to $49.6 million. This non-dilutive capital injection strengthens the regenerative medicine company's balance sheet as it scales the global commercialization of its nerve and tissue repair products.
Full story: https://getfinancebrief.com/story/orthocell-cash-reserves-rd-tax-refund

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.